资源描述:
《pparγ配体罗格列酮对大鼠扩张型心肌病的疗效及可能机制》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、PPARγ配体罗格列酮对大鼠扩张型心肌病的疗效及可能机制【摘要】观察PPARγ配体罗格列酮对多柔比星诱导的扩张型心肌病的治疗作用,并探讨可能机制。方法:30只雄性SD大鼠随机分为(1)正常对照组(CON,n=10),等体积生理盐水灌胃;(2)扩张型心肌病组(DCM,n=10),多柔比星2.0mg·kg-1腹腔注射,每周1次,共8周;(3)扩张型心肌病+罗格列酮组(DCM+RSG,n=10),罗格列酮3.0mg·kg-1·d-1灌胃治疗,共12周。第15周检测心肌相关炎症因子浓度以及总抗氧化能力(TAOC)、丙二醛(MDA)浓度;检测心功能。结果:D
2、CM组与CON组相比左室射血分数(LVEF),+dp/dtmax,-dp/dtmax,TAOC显著降低(P<0.05)。心肌中TNFα,IL1β,IL6,MDA及胶原容积百分数(CVF)明显升高(P<0.05),罗格列酮治疗后LVEF,TAOC有所改善(P<0.05),TNFα,IL1β,IL6,MDA,CVF有所降低(P<0.05)。结论:PPARγ配体罗格列酮可改善扩张型心肌病大鼠的心功能,其机制可能是提高心肌抗氧化能力、减少炎症因子的释放。【关键词】过氧化物酶体增殖物激活受体γ扩张型心肌病化应激炎症因子[Abstract]Obje
3、ctive:Toobservetheeffectofadministrationperoxisomeproliferatoractivatedreceptorγ15agonistRosiglitazoneondilatedcardiomyopathy(DCM)ratsinducedbyadriamycinanditsmechanism.Methods:ThirtymaleSpragueDawleyratswererandomlydividedinto3groupsasfollows.1)thecontrolgroup(CON,n=10):Th
4、esamedoseofnormalsodiumwasadministeredbydailygavage.2)thedilatedcardiomyopathygroup(DCM,n=6):Adriamycinwasadministeredintraperitoneallyfor8weeks.3)thedilatedcardiomyopathy+Rosiglitazonegroup(DCM+RSG,n=6).concomitantadriamycinandrosiglitazone,rosiglitazoneadministereddailygavag
5、eatadoseof3mg·kg-1·d-1for12weeks.TheconcentrationofTNFα,IL6,IL1β,TAOC,MDAinmyocardiumwereobtainedat15weeksaftertreatment.Thecardiacfunctionwasassessedbyechocardiography,hemodynamicsatthesametime.Results:TocomparetheDCMgroupwiththeCONgroup,significantlydecreaseofleftventricu
6、larejectionfraction(LVEF),+dp/dtmax,-dp/dtmaxandTAOCwasobserved(P<0.05),whiletheconcentrationofTNFα,IL1β,IL6,MDAinmyocardium,collagenvolumefraction(CVF)wereallsignificantlyincreased(P<0.05).LVEF,TAOCwereimproved(P<0.05)byrosiglitazonetreatment.ConcentrationofTNFα,IL1β,IL
7、6,MDAinmyocardiumandCVFweredecreased(P<0.05)byrosiglitazonetreatment.Conclusion:Proliferatoractivated15receptorγagonistrosiglitazonecanimprovecardiacfunctioninaratmodelofdilatedcardiomyopathyinducedbyadriamycin,andtheantiinflammatory,antioxidativestressmightbetwoofthemechan
8、isms.[Keywords]PPARγ;dilatedcardiomyopathy;oxidativestress;in